|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Departments of Obstetrics and Gynecology,3
Pediatrics,4
Pathology,5 Keck School of Medicine, University of Southern California, Los Angeles, California 90033
Contraceptive microbicides formulated as vaginal gels offer the possibility of women-controlled contraception and prevention of HIV infection. The effects of these gels on the upper reproductive tract are largely unknown. The purpose of this study was to determine whether nonoxynol-9 (N-9) induces apoptosis in human endometrium using endometrial explant as a model. Apoptosis was determined by gel electrophoresis for the detection of DNA fragmentation and by immunohistochemistry using the M30 CytoDEATH and anti-cleaved caspase-3 (CASP3) antibodies for the detection of caspase activity. The ability of the broad-spectrum caspase inhibitor and CASP3-specific inhibitor to prevent N-9-induced cell death was measured. Expression of apoptosis-related genes such as BCL2, BAX, Fas receptor (FAS), and Fas ligand (FASLG) was quantified using real-time polymerase chain reaction (PCR) analysis. This study demonstrated that N-9 induced DNA fragmentation and caspase activity in endometrial explants in a dose- and time-dependent manner. Caspase inhibitors did not fully prevent the N-9-induced DNA fragmentation. Real-time PCR analysis revealed that FAS and FASLG were largely increased following N-9 treatment. Together, these results suggested that apoptosis triggered by N-9 in endometrial explants is mediated upstream via FAS and FASLG, followed by CASP3 activation leading to final cell death. It appears that other factors besides caspases are also involved in the N-9-induced apoptosis.
apoptosis, caspase activation, endometrial explants, female reproductive tract, gene expression, gene regulation, nonoxynol-9, uterus
2 Correspondence: John K. Jain, Department of Obstetrics and Gynecology, The Keck School of Medicine of the University of Southern California, 1240 Mission St., Room 1M20, Los Angeles, CA 90033. FAX: 323 226 2850; jjain{at}usc.edu
This article has been cited by other articles:
![]() |
R. K. Jain, A. Jain, J. P. Maikhuri, V. L. Sharma, A. K. Dwivedi, S.T.V.S. Kiran Kumar, K. Mitra, V. K. Bajpai, and G. Gupta In vitro testing of rationally designed spermicides for selectively targeting human sperm in vagina to ensure safe contraception Hum. Reprod., March 1, 2009; 24(3): 590 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. J. D'Cruz and F. M. Uckun Preclinical Evaluation of a Dual-Acting Microbicidal Prodrug WHI-07 in Combination with Vanadocene Dithiocarbamate in the Female Reproductive Tract of Rabbit, Pig, and Cat Toxicol Pathol, December 1, 2007; 35(7): 910 - 927. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Jain, A. Li, W. Yang, P. Minoo, and J. C. Felix Effects of mifepristone on proliferation and apoptosis of human endometrium in new users of medroxyprogesterone acetate Hum. Reprod., March 1, 2006; 21(3): 798 - 809. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |